CRUS trades 40.9% below Wall Street's consensus target of $160.00.
Last 12 months price action with 12-month analyst target path
The base valuation assumes CRUS achieves its forward estimates and maintains a stable P/E multiple of 12.5x. This scenario reflects the blended consensus of 22 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
As of November 7, 2026, Cirrus Logic, Inc. (CRUS) has a Wall Street consensus price target of $160.00, based on estimates from 22 covering analysts. With the stock currently trading at $113.58, this represents a potential upside of +40.9%. The company has a market capitalization of $5.73B.
Analyst price targets range from a low of $130.00 to a high of $190.00, representing a 38% spread in expectations. The median target of $160.00 aligns closely with the consensus average.
The current analyst consensus rating is Buy, with 14 analysts rating the stock as a Buy or Strong Buy,5 rating it Hold, and 3 rating it Sell or Strong Sell. The positive sentiment balance indicates moderate optimism about the stock prospects.
From a valuation perspective, CRUS trades at a trailing P/E of 14.1x and forward P/E of 12.5x. The forward PEG ratio of 0.75 suggests the stock may be undervalued relative to its growth. Analysts expect EPS to grow +10.2% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $132.84, with bear and bull scenarios of $83.69 and $175.03 respectively. Model confidence stands at 52/100, reflecting moderate uncertainty in projections.
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
 SYNASynaptics Incorporated | $4.6B | $116.70 | $129.33 | +10.8% | Buy | 25.3x | 34 |
 MTSIMACOM Technology Solutions Holdings, Inc. | $16.1B | $210.98 | $371.11 | +75.9% | Buy | 38.3x | 25 |
 DIODDiodes Incorporated | $3.6B | $77.36 | $145.67 | +88.3% | Buy | 23.8x | 14 |
 SLABSilicon Laboratories Inc. | $7.3B | $221.50 | $183.40 | -17.2% | Buy | 76.2x | 38 |
 POWIPower Integrations, Inc. | $2.2B | $40.26 | $72.33 | +79.7% | Buy | 28.2x | 17 |
 ADIAnalog Devices, Inc. | $177.1B | $363.56 | $480.24 | +32.1% | Buy | 28.2x | 54 |
 TXNTexas Instruments Incorporated | $253.3B | $277.36 | $333.71 | +20.3% | Buy | 30.7x | 66 |
 SWKSSkyworks Solutions, Inc. | $12.4B | $82.19 | $82.27 | +0.1% | Buy | 16.3x | 60 |
 AAPLApple Inc. | $5.0T | $342.37 | $344.46 | +0.6% | Buy | 36.2x | 112 |
 QCOMQUALCOMM Incorporated | $173.7B | $165.41 | $205.50 | +24.2% | Hold | 15.7x | 69 |
Quick answers to the most common questions about buying CRUS stock.
The consensus Wall Street price target for CRUS is $160, representing 40.9% upside from the current price of $113.58. With 22 analysts covering the stock, this strong upside suggests significant value not yet reflected in today's share price.
CRUS has a consensus rating of "Buy" based on 22 Wall Street analysts. The rating breakdown is predominantly bullish, with 14 Buy/Strong Buy ratings. The consensus 12-month price target of $160 implies 40.9% upside from current levels.
With a forward P/E of 12.5291x, CRUS trades at a relatively low valuation. The consensus target of $160 implies 40.9% appreciation, suggesting meaningful undervaluation.
The most bullish Wall Street analyst has a price target of $190 for CRUS, while the most conservative target is $130. The consensus of $160 represents the median expectation. Our quantitative valuation model projects a bull case target of $175 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
CRUS is well covered by analysts, with 22 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 14 have Buy ratings, 5 recommend Hold, and 3 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month CRUS stock forecast based on 22 Wall Street analysts shows a consensus price target of $160, with estimates ranging from $130 (bear case) to $190 (bull case). The median consensus rating is "Buy". Our proprietary valuation model produces a base case fair value of $133, with bear/bull scenarios of $84/$175.
Our quantitative valuation model calculates CRUS's fair value at $133 (base case), with a bear case of $84 and bull case of $175. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 52/100.
CRUS trades at a forward P/E ratio of 12.5x based on next-twelve-months earnings estimates compared to a trailing P/E of 14.1x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Wall Street analysts are very optimistic on CRUS, with a "Buy" consensus rating and $160 price target (40.9% upside). 14 of 22 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
CRUS analyst price targets range from $130 to $190, a 38% moderate spread showing some variance in outlooks. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $160 consensus represents the middle ground. Our model's $84-$175 range provides an independent fundamental perspective.
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.